Invention Grant
![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/docs/US/2018-05-01/US09957275B2/abs.jpg.600x600.jpg)
- Patent Title: Pyrazolo[1,5-A]pyrimidines for antiviral treatment
-
Application No.: US15639970Application Date: 2017-06-30
-
Publication No.: US09957275B2Publication Date: 2018-05-01
- Inventor: Kerim Babaoglu , Constantine G. Boojamra , Eugene J. Eisenberg , Hon Chung Hui , Richard L. Mackman , Jay P. Parrish , Michael Sangi , Oliver L. Saunders , Dustin Siegel , David Sperandio , Hai Yang
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: Gilead Sciences, Inc.
- Current Assignee: Gilead Sciences, Inc.
- Current Assignee Address: US CA Foster City
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D487/08 ; C07D495/04 ; C07D513/04 ; A61K31/519 ; A61K45/06 ; A61K31/5377 ; A61K31/55 ; A61K31/551 ; A61K31/675 ; C07F9/6561 ; C07D519/00
![Pyrazolo[1,5-A]pyrimidines for antiviral treatment](/abs-image/US/2018/05/01/US09957275B2/abs.jpg.150x150.jpg)
Abstract:
The invention provides compounds of Formula I or Formula II: or a pharmaceutically acceptable salt or ester, thereof, as described herein. The compounds and compositions thereof are useful for treating Pneumovirinae virus infections. The compounds, compositions, and methods provided are particularly useful for the treatment of Human respiratory syncytial virus infections.
Public/Granted literature
- US20170362244A1 PYRAZOLO[1,5-A]PYRIMIDINES FOR ANTIVIRAL TREATMENT Public/Granted day:2017-12-21
Information query
